Document Detail


Kupffer cell activation by hydrogen peroxide: a new mechanism of portal pressure increase.
MedLine Citation:
PMID:  20118678     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study aimed to investigate the effects of reactive oxygen species on the hepatic macrophages, the Kupffer cells (KC), and to identify the relevant targets of vasoconstrictors involved in the regulation of intrahepatic microcirculation and therefore portal pressure. The effects of hydrogen peroxide (H2O2), xanthine/xanthine oxidase or a thromboxane (TX) analogue (U46619; 0.1 microM) were tested in sham-operated and fibrotic livers (bile duct ligation over 4 weeks) during isolated rat liver perfusion and in vivo with or without additional KC blockade (gadolinium chloride, 10 mg kg(-1) body weight, 48 and 24 h, i.p.). To investigate downstream mechanisms, a TXA2 antagonist (BM 13.177; 20 microM) or a Rho kinase inhibitor (Y27632; 10 microM) was infused additionally. TXB2 efflux was measured by enzyme-linked immunosorbent assay. The phosphorylation state of moesin (p-moesin), as indicator for Rho kinase activity, was assessed by Western blot analyses. Portal pressure was dose-dependently increased by H2O2 (maximum, 0.5 mM) and, to a lower extent, by xanthine/xanthine oxidase together with catalase. The portal pressure increase by H2O2 was attenuated by previous KC blockade. TXA2 efflux increased after H2O2 infusion and was reduced by KC blockade. The TXA2 antagonist counteracted the H2O2-induced increase in portal pressure. The Rho kinase inhibitor attenuated portal pressure increase after TXA2 analogue or H2O2 infusion. Hepatic levels of p-moesin were increased after H2O2 infusion. Reactive oxygen species increased portal pressure via stimulation of TXA2 production by KCs and a subsequent Rho kinase-dependent contraction of the intrahepatic vasculature. In conclusion, the KCs that are well known to produce H2O2 could also be activated by H2O2. This vicious cycle may best be interrupted at the earliest time point.
Authors:
Christian J Steib; Manfred Bilzer; Josef M Härtl; Frigga Beitinger; Veit Gülberg; Burkhard Göke; Alexander L Gerbes
Related Documents :
11487548 - Hemodynamic effects of the angiotensin ii receptor antagonist irbesartan in patients wi...
11325028 - Utilization of telemetry system to assess the cardiovascular profile of ah-1058, a new ...
9861778 - Portal levels of the isoprostane f2 alpha-iii, a marker of lipid peroxidation, do not c...
11499708 - Ultrasonography of the normal feline pancreas and associated anatomic landmarks: a pros...
16863478 - The challenge of blood pressure management in neurologic emergencies.
3231898 - Maximum respiratory pressures in morbidly obese subjects.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Shock (Augusta, Ga.)     Volume:  33     ISSN:  1540-0514     ISO Abbreviation:  Shock     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-04-26     Completed Date:  2010-07-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9421564     Medline TA:  Shock     Country:  United States    
Other Details:
Languages:  eng     Pagination:  412-8     Citation Subset:  IM    
Affiliation:
Department of Medicine II (Gastroenterology and Hepatology), University of Munich-Grosshadern, Munich, Germany. christian.steib@med.uni-muenchen.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / pharmacology
Amides / pharmacology
Animals
Gadolinium / pharmacology
Hydrogen Peroxide / pharmacology*
Kupffer Cells / drug effects*,  physiology
Liver Cirrhosis / physiopathology
Male
Microfilament Proteins / metabolism
Portal Pressure / drug effects*
Pyridines / pharmacology
Rats
Rats, Sprague-Dawley
Reactive Oxygen Species / pharmacology
Sulfonamides / pharmacology
Xanthine / pharmacology
Xanthine Oxidase / pharmacology
Chemical
Reg. No./Substance:
0/Amides; 0/Microfilament Proteins; 0/Pyridines; 0/Reactive Oxygen Species; 0/Sulfonamides; 10138-52-0/gadolinium chloride; 138381-45-0/Y 27632; 144131-77-1/moesin; 69-89-6/Xanthine; 72131-33-0/sulotroban; 7440-54-2/Gadolinium; 76898-47-0/15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 7722-84-1/Hydrogen Peroxide; EC 1.17.3.2/Xanthine Oxidase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sentinel Surveillance of Rectal Chlamydia and Gonorrhea Among Males-San Francisco, 2005-2008.
Next Document:  Immunogenicity of a 2-Dose Priming and Booster Vaccination With the 10-Valent Pneumococcal Nontypeab...